cambridge healthtech institute · key events 2015 2016 march 6-11, 2016 miscone north convention...

healthtech.comCambridge Healthtech Institute250 First Avenue, Suite 300 | Needham, MA 02494T: (781) 972-5400 or Toll-free in the U.S. 888-999-6288 | F: (781) 972-5425

Cambridge Healthtech InstituteYour Life Science Network

Conference & Course CatalogAugust 2015 – February 2016

2 | Cambridge Healthtech Institute

For over 20 years, Cambridge Healthtech Institute has developed more than 800 conferences, which have attracted over 60,000 attendees from around the world. CHI is the industry leader in offering quality programs that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments in the life science industry. Leading researchers and business experts from top pharmaceutical, biotech, and academic organizations present their most current findings in a forum that features panel discussions and audience participation.

Each year, CHI organizes over 170 annual events geared to the biotech and pharmaceutical industries with specific focuses on Biomarkers, Genomics, Proteins and Proteomics, Drug Discovery & Development, IT and Informatics, Chemistry, Diagnostics & Safety, and Business.

For a comprehensive listing and detailed information about our products and services, please visit: healthtech.com.

About Cambridge Healthtech Institute

Follow us

TABLE OF CONTENTS

CONFERENCE SERIESBiological Therapeutic Products ...................................................... 4Biomarkers and Diagnostics ........................................................... 4Bioprocess and Manufacturing ....................................................... 4Clinical Trials & Translational Medicine ............................................ 5Chemistry ....................................................................................... 5BioPharmaceutical Strategy ............................................................ 6Drug Discovery & Development ..................................................... 6Drug Targets .................................................................................... 7Genomics ........................................................................................ 7Healthcare ....................................................................................... 7Informatics and IT ........................................................................... 8Therapeutic Indications ................................................................... 8Technology and Tools for Life Sciences ........................................... 9

CONFERENCES BY DATE WITH DETAIL ................................... 10-13

SHORT COURSE SCHEDULE .................................................... 14-15

CUSTOMER SERVICEPamela GerardiDirector of Customer ServiceE: [email protected] | T: 781-972-5409

Kris WatermanSr. Customer Service RepresentativeE: [email protected] | T: 781-972-5413

Rose LaRaiaCustomer Service RepresentativeE: [email protected] | T: 781-972-5400

MARKETINGJim MacNeilVice President of MarketingE: [email protected] | T: 781-972-5441

Rich HandySenior Director of MarketingE: [email protected] | T: 781-972-5456

SPONSOR & EXHIBIT SALESAngela ParsonsVice President of Business DevelopmentE: [email protected] | T: 781-972-5467

Carol DinersteinDirector, Business DevelopmentE: [email protected] | T: 781-972-5471

GROUP SALES David CunninghamDirector, Inside SalesE: [email protected] | T: 781-972-5472

GRAPHICSThomas NortonDesign DirectorE: [email protected] | T: 781-972-5440

PRODUCTIONEdel O’ Regan, Ph.D.Vice President of ProductionE: [email protected] | T: 781-972-5423

Christina LinghamExecutive Director of ConferencesE: [email protected] | T: 781-972-5464

Mary Ann BrownExecutive Director of ConferencesE: [email protected] | T: 781-972-5497

Julia Boguslavsky Executive Director of ConferencesE: [email protected] | T: 760-732-3139

Micah LiebermanExecutive Director of ConferencesE: [email protected] | T: 541-482-4709

CONTACT US

@CHI_Healthtech

linkedin.com/company/cambridge-healthtech-institute

youtube.com/user/cambridgehealthtech

Cambridge Healthtech Institute 250 First Avenue, Suite 300 | Needham, MA 02494

T: (781) 972-5400 or Toll-free in the U.S. 888-999-6288

F: (781) 972-5425

August 2015 – February 2016 Catalog | 3

KEY EVENTS

2015

2016

March 6-11, 2016Miscone North Convention CenterSan Francisco, CA

TriConference.com

June 15-17, 2016Westin Boston WaterfrontBoston, MA

WorldPharmaCongress.com

The Protein Science Week

January 18-22, 2016Town and Country Resort & Convention CenterSan Diego, CA

CHI-PepTalk.com

April 5-7, 2016Seaport World Trade CenterBoston, MA

Bio-ITWorldExpo.com

September 21-24, 2015Westin Boston WaterfrontBoston, MA

DiscoveryOnTarget.com

August 18-20, 2015Capital Hilton HotelWashington, DC

NextGenerationDx.com

August 3-7, 2015Westin Copley PlaceBoston, MA

BioprocessingSummit.com

THE BIOPROCESSING SUMMIT

August 24-28, 2015Marriott Long Wharf HotelBoston, MA

ImVacs.com

February 22-25, 2016Hyatt Regency MiamiMiami, FL

SCOPESummit

Summit for Clinical Trials Operations Execs

April 5-7, 2016Jin Mao TowerPudong, Shanghai, China

PEGSummitChina.com

The Essential Protein Engineering SummitCHINA

Drug Discovery ChemistryApril 19-22, 2016Hilton San Diego ResortSan Diego, CA

DrugDiscoveryChemistry.com

April 25-29, 2016World Trade CenterBoston, MA

PEGSummit.com

The Essential Protein Engineering SummitBOSTON

November 2-6, 2015EPIC SANA Lisboa HotelLisbon, Portugal

PEGSummitEurope.com

The Essential Protein Engineering Summit

EUROPE

September 1-3, 2015JW Marriott SeoulSeocho-gu Seoul, Korea

PEGSummitKorea.com

The Essential Protein Engineering Summit

KOREA

May 17-19, 2016Philadelphia Downtown MarriottPhiladelphia, PA

BiomarkerWorldCongress.com

BIOMARKERS DIAGNOSTICSW O R L D C O N G R E S S

&


Conferences by Series

Biological Therapeutic Products

Diagnostics to Guide Cancer Immunotherapy August 19-20, 2015 • Washington, DC

IMVACS: The Immunotherapies & Vaccine SummitAugust 24-28, 2015 • Boston, MA

Immunomodulatory Therapeutic Antibodies for Cancer August 24-25, 2015 • Boston, MANovel Vaccines Part I: AdjuvantsAugust 24-25, 2015 • Boston, MANovel Vaccines Part II: Emerging Technologies August 25-26, 2015 • Boston, MATarget Discovery for T Cell TherapyAugust 27-28, 2015 • Boston, MAGene Editing for Immunotherapy August 27-28, 2015 • Boston, MAPEGS KoreaSept. 1-3, 2015 • Seocho-gu Seoul KoreaGPCR-Based Drug Discovery Part 2 September 23-24, 2015 • Boston, MA

Antibodies Against Membrane Protein Targets Part 2 September 23-24, 2015 • Boston, MAPEGS Europe SummitNovember 2-6, 2015 • Lisbon Portugal Optimization & Development of Biologics November 2-3, 2015 • Lisbon PortugalDisplay of AntibodiesNovember 2-3, 2015 • Lisbon PortugalProtein Purification TechnologiesNovember 2-3, 2015 • Lisbon PortugalEngineering Expression SystemsNovember 2-3, 2015 • Lisbon PortugalBioreactor Design & EngineeringNovember 4-5, 2015 • Lisbon Portugal

Bispecifics and Novel BiotherapeuticsNovember 4-5, 2015 • Lisbon Portugal

Applying Expression Platforms November 4-5, 2015 • Lisbon Portugal

Protein Aggregates & ParticlesNovember 4-5, 2015 • Lisbon Portugal

Bioproduction: Scaling Up & Down November 5-6, 2015 • Lisbon Portugal

Cancer BiotherapeuticsNovember 5-6, 2015 • Lisbon Portugal

Analytical Characterization of BiotherapeuticsNovember 5-6, 2015 • Lisbon Portugal

Protein Formulation & StabilityNovember 5-6, 2015 • Lisbon Portugal Immunogenicity & Bioassay SummitNovember 17-19, 2015 • Baltimore, MD

Immunogenicity Assessment & Clinical RelevanceNovember 17-18, 2015 • Baltimore, MD

Immunogenicity Prediction & MitigationNovember 18-19, 2015 • Baltimore, MD

Optimizing Bioassays for BiologicsNovember 18-19, 2015 • Baltimore, MD

PepTalkJanuary 18-22, 2016 • San Diego, CA

Next Generation Dx Summit August 18-20, 2015 • Washington, DC

Predictive Cancer BiomarkersAugust 18-19, 2015 • Washington, DC

Companion DiagnosticsAugust 18-19, 2015 • Washington, DC

Coverage and Reimbursement of Advanced DiagnosticsAugust 18-19, 2015 • Washington, DC

Clinical NGS AssaysAugust 18-19, 2015 • Washington, DC

Molecular Diagnostics for Infectious DiseaseAugust 19-20, 2015 • Washington, DC

Enabling Point-of-Care DiagnosticsAugust 18-19, 2015 • Washington, DCDiagnostics to Guide Cancer ImmunotherapyAugust 19-20, 2015 • Washington, DCCommercialization of Molecular DiagnosticsAugust 19-20, 2015 • Washington, DC

Clinical Application of Cell-Free DNAAugust 19-20, 2015 • Washington, DC

Leveraging Pharmacies for Rapid DiagnosticsAugust 19-20, 2015 • Washington, DC

NGS DiagnosticsAugust 19-20, 2015 • Washington, DC

Targeting the MicrobiomeSeptember 22-23, 2015 • Boston, MA

Targeting Ocular Disorders September 22-23, 2015 • Boston, MAKinase Inhibitor DiscoverySeptember 23-24, 2015 • Boston, MA

Digital PCRNovember 2-4, 2015 • San Diego, CA

Advances in Prenatal Molecular DiagnosticsNovember 16-18, 2015 • Boston, MA

Diagnostics to Guide Antimicrobial Stewardship and Drug DevelopmentNovember 17-18, 2015 • Boston, MA

Reproductive Genetic DiagnosticsNovember 18-19, 2015 • Boston, MA



The Bioprocessing Summit August 3-7, 2015 • Boston, MA

Protein Purification TechnologiesNovember 2-3, 2015 • Lisbon Portugal

Bioreactor Design & EngineeringNovember 4-5, 2015 • Lisbon Portugal

Bioproduction: Scaling Up & DownNovember 5-6, 2015 • Lisbon Portugal Immunogenicity Assessment & Clinical RelevanceNovember 17-18, 2015 • Baltimore, MD


Optimizing Bioassays for BiologicsNovember 18-19, 2015 • Baltimore, MD

PepTalkJanuary 18-22, 2016 • San Diego, CA

GPCR-Based Drug Discovery Part 1September 22-23, 2015 • Boston, MA

Targeting the Unfolded Protein ResponseSeptember 23-24, 2015 • Boston, MA

GPCR-Based Drug Discovery Part 2 September 23-24, 2015 • Boston, MA

Quantitative Systems PharmacologySeptember 23-24, 2015 • Boston, MA

Strategic Resource ManagementNovember 2-3, 2015 • Philadelphia, PA

Portfolio ManagementNovember 3-4, 2015 • Philadelphia, PA

Clinical Development and Commercialization of AntibacterialsNovember 17-18, 2015 • Boston, MA

Immunogenicity & Bioassay SummitNovember 17-19, 2015 • Baltimore, MD

Summit for Clinical Ops Executives (SCOPE)February 23-25, 2016 • Miami, FL

Global Site Selection, Feasibility Assessment, Operations and Site ManagementFebruary 23-24, 2016 • Miami, FL

Enrollment Planning and Patient RecruitmentFebruary 23-24, 2016 • Miami, FL

Clinical Trial Forecasting and BudgetingFebruary 23-24, 2016 • Miami, FL

Implementing Risk-Based Monitoring (Part 1)February 23-24, 2016 • Miami, FL

Clinical IT Strategy and GovernanceFebruary 23-24, 2016 • Miami, FL

Managing Late Stage Research and Observational StudiesFebruary 23-24, 2016 • Miami, FL

Improving Site-Study Activation and PerformanceFebruary 24-25, 2016 • Miami, FL

Patient Engagement, Enrollment and Retention through Communities and TechnologyFebruary 24-25, 2016 • Miami, FL

Managing Outsourced Clinical TrialsFebruary 24-25, 2016 • Miami, FL

Implementing Risk-Based Monitoring (Part 2)February 24-25, 2016 • Miami, FL

Clinical Data Technology and IntegrationFebruary 24-25, 2016 • Miami, FL

Leveraging Existing Data for Clinical and Observational ResearchFebruary 24-25, 2016 • Miami, FL

Discovery on Target September 21-24, 2015 • Boston, MA


Targeting Epigenetic Readers and Chromatin RemodelersSeptember 22-23, 2015 • Boston, MA

Kinase Inhibitor DiscoverySeptember 23-24, 2015 • Boston, MA



Targeting Histone Methyltransferases and DemethylasesSeptember 23-24, 2015 • Boston, MA



Companion Diagnostics August 18-19, 2015 • Washington, DC


Strategic Resource ManagementNovember 2-3, 2015 • Philadelphia, PA

Portfolio ManagementNovember 3-4, 2015 • Philadelphia, PA


Summit for Clinical Ops Executives (SCOPE) February 23-25, 2016 • Miami, FL

IMVACS-The Immunotherapies & Vaccine SummitAugust 24-28, 2015 • Boston, MA

Immunomodulatory Therapeutic Antibodies for CancerAugust 24-25, 2015 • Boston, MA

PEGS KoreaSept. 1-3, 2015 • Seoul Korea

Discovery on TargetSeptember 21-24, 2015 • Boston, MA

New Frontiers in Gene EditingSeptember 23-24, 2015 • Boston, MA



Antibodies Against Membrane Protein Targets Part 2September 23-24, 2015 • Boston, MA



Targeting the Ubiquitin Proteasome SystemSeptember 22-23, 2015 • Boston, MA

RNAi for Functional Genomics ScreeningSeptember 22-23, 2015 • Boston, MA




Gene Therapy BreakthroughsSeptember 22-23, 2015 • Boston, MA

Targeting Ocular DisordersSeptember 22-23, 2015 • Boston, MA



Optimization & Development of BiologicsNovember 2-3, 2015 • Lisbon Portugal

Display of AntibodiesNovember 2-3, 2015 • Lisbon Portugal

Engineering Expression SystemsNovember 2-3, 2015 • Lisbon Portugal

Bispecifics and Novel BiotherapeuticsNovember 4-5, 2015 • Lisbon Portugal

Applying Expression PlatformsNovember 4-5, 2015 • Lisbon Portugal


Cancer BiotherapeuticsNovember 5-6, 2015 • Lisbon Portugal


Protein Formulation & StabilityNovember 5-6, 2015 • Lisbon Portugal

FAST: Functional Analysis & Screening Technologies CongressNovember 9-11, 2015 • Boston, MA

3D Cell Culture: Organoid, Spheroid, and Organ-on-a-Chip ModelsNovember 9-10, 2015 • Boston, MA

Phenotypic Drug DiscoveryNovember 9-10, 2015 • Boston, MA

Screening Strategies for Cancer ImmunotherapyNovember 10-11, 2015 • Boston, MA

Screening and Functional Analysis of 3D ModelsNovember 10-11, 2015 • Boston, MA

Antibacterial Research and DevelopmentNovember 16-17, 2015 • Boston, MA





Drug TargetsSERIES


Next Generation Histone Deacetylose InhibitorsSeptember 21, 2015 • Boston, MA







Kinase Inhibitor DiscoverySeptember 23-24, 2015 • Boston, MATargeting the Unfolded Protein ResponseSeptember 23-24, 2015 • Boston, MA








Re- Entering Antibacterial Drug Development SummitNovember 16-18, 2015 • Boston, MA





Antibodies Against Membrane Protein Targets Part 1 September 22-23, 2015 • Boston, MAGene Therapy BreakthroughsSeptember 22-23, 2015 • Boston, MA

New Frontiers in Gene Editing September 23-24, 2015 • Boston, MA



Reproductive Genetic Diagnostics November 18-19, 2015 • Boston, MAPrenatal Molecular Diagnostics November 16-18, 2015 • Boston, MA


Reproductive Genetic DiagnosticsNovember 18-19, 2015 • Boston, MA

Prenatal Molecular Diagnostics November 16-18, 2015 • Boston, MA



Converged IT Summit 2015Sept. 9-10, 2015 • San Francisco, CA

Quantitative Systems PharmacologySeptember 23, 2015 • Boston, MA

Summit for Clinical Ops Executives (SCOPE)February 23-25, 2016 • Miami, FL

SERIESImmunomodulatory Therapeutic Antibodies for CancerAugust 24-25, 2015 • Boston, MA

PEGS Korea September 1-3, 2015 • Seocho-gu Seoul Korea













Antibacterial Research and DevelopmentNovember 16-17, 2015 • Boston, MA



LIFE SCIENCE

MEDIALIBRARY

Continue Your Education with CHI’s Digital Courses

Navigate, pause, rewind and listen to recorded sessions in a multimedia presentation. Visit CHI’s Life Science Media Library to view over 120 digital courses recorded at our most successful events.

Formats available:Digital DownloadOn DemandDVD

Healthtech.com/MediaLibraryOrder Today


Next Generation Dx SummitAugust 18-19, 2015 • Washington, DC

Clinical NGS AssaysAugust 18-19, 2015 • Washington, DC

Clinical Application of Cell-Free DNAAugust 19-20, 2015 • Washington, DC

Leveraging Pharmacies for Rapid DiagnosticsAugust 19-20, 2015 • Washington, DC


Novel Vaccines Part II: Emerging TechnologiesAugust 25-26, 2015 • Boston, MA

Gene Editing for Immunotherapy August 27-28, 2015 • Boston, MA

Converged IT Summit 2015Sept. 9-10, 2015 • San Francisco, CA








New Frontiers in Gene EditingSeptember 23-24, 2015 • Boston, MA







FAST: Functional Analysis & Screening Technologies CongressNovember 9-11, 2015 • Boston, MA




Sensors Global SummitNovember 10-11, 2015 • La Jolla, CA


Diagnostics to Guide Antimicrobial Stewardship and Drug Development November 17-18, 2015 • Boston, MA

Immunogenicity Assessment & Clinical RelevanceNovember 17-18, 2015 • Baltimore, MD


Optimizing Bioassays for Biologics November 18-19, 2015 • Baltimore, MD

PepTalk January 18-22, 2016 • San Diego, CA

Practical Applications of NMR in Industry (PANIC) February 16-18, 2016 • Houston, TX

ONE STOP SHOP AFFILIATED REPORTSCOLLECTION

for Over 1,000 Life Science Reports Spanning over 50 Research Areas

Insight Pharma Reports offers:

4 Market Data4 Pipeline Data4 Clinical Trial Data

4 Market Research4 Custom Reports4 Bundled Report Packages

For more information, contact Kerri Kelley at: [email protected] or call (781) 972-1347

InsightPharmaReports.com

Just some of the Reports Available Include:

• Alzheimer’s Disease• Biomarkers & Diagnostics• BioPharma Strategy• Biosimilars & Generic Markets• Cancer Research and Therapeutics• Chemistry• Clinical Trials & Translational

• Medicine• Data Mining• Drug Discovery & Development• Health IT• Infectious Disease• Medical Devices• Multiple Sclerosis• Ocular• Pain Management• Pharmaceutical Marketing• Sequencing• Vaccines

...and many others

An Essential Collection of Timely & Concise Reports Analyzing the Technologies, Markets, and Strategic Issues Driving R&D Productivity. Available through Insight Pharma Reports and our Network of Affiliated Reports.


The Bioprocessing Summit August 3-7, 2015 • Boston, MAThe 2015 Bioprocessing Summit plans to unite 750+ attendees from 30+ countries for five days of inspiring presentations and solutions. The Bioprocessing Summit brings together international leaders to discuss today’s bioprocess issues from cell line selection to manufacturing. The Summit provides practical details in a relaxed, congenial atmosphere that promotes information exchange and networking.

This leading bioprocess meeting is hosted in Boston each summer. Hundreds of bioprocess professionals come together each year at the Summit to share practical solutions for today’s bioprocess challenges with researchers from around the world.

Spanning five days, the 2015 meeting includes 12 conference programs, 8 training seminars and 10 short courses.BioprocessingSummit.com

Next Generation Dx SummitAugust 18-20, 2015 • Washington, DCThe Next Generation Dx Summit, entering its seventh year, brings together more than 800 diagnostics professionals from across the world, providing comprehensive programming and valuable networking opportunities. Spanning from clinical diagnostics to business strategy, this year’s expanded program encompasses predictive cancer biomarkers, companion diagnostics, infectious disease, point-of-care, pharmacy-based diagnostics, cell-free DNA, commercialization, cancer immunotherapy, and reimbursement. With widespread coverage of all the most relevant diagnostics topics, the Next Generation Dx Summit promises to be a must-attend event to hear the latest announcements and developments in this rapidly evolving field.NextGenerationDx.com

ImVacS: Immunotherapy and Vaccine SummitAugust 24-28, 2015 • Boston, MACambridge Healthtech Institute is pleased to bring you the Tenth Annual ImVacS: Immunotherapy and Vaccine Summit. From its beginnings as a lone adjuvants conference, ImVacS has grown to a multi-track event spanning vaccines, immunotherapies, and platform technologies. This year’s event has been expanded to five days with coverage on adjuvants, vaccine and immunotherapy technologies, immunomodulatory therapeutic antibodies for cancer, combination cancer immunotherapy, and T cell target discovery. ImVacS 2015 promises to be a must-attend event for commercial and academic entities to continue advancing immunotherapies and vaccines through technology and innovation.ImVacs.com

PEGS Summit KoreaSeptember 1-3, 2015 • Seocho-gu Seoul KoreaPEGS is CHI’s flagship biologics meeting, and is widely considered the industry’s leading event on protein and antibody engineering. Its successful accolades include an annual attendance of over 1,800 participants at the PEGS Summit in Boston, a record attendance of over 500 attendees at PEGS Europe last year, a successful launch of PEGS China in 2014, and now, we proudly announce PEGS Korea.

This three-day inaugural event will bring together an international faculty of scientists, professors and managers from leading universities, research laboratories and biopharmaceutical companies to share practical applications and case examples in protein and antibody engineering and novel biotherapeutics development.PEGSummitKorea.com

Converged IT SummitSeptember 9-10, 2015 • Boston, MASeptember 9-10, 2015 • San Francisco, CA

This two-day Summit will cover a broad range of topics that will frame the issues behind creating computational solutions for modern research methodologies. Topics will include: technologies currently in use, how organizations are using them to accelerate discovery, efforts that have worked and those that have failed, organizational challenges and policies for research computing, and the art of converged infrastructure as a research tool.ConvergedITSummit.com

Discovery on TargetSeptember 21-24, 2015 • Boston, MAThe13th Annual Discovery on Target event showcasing current and emerging “hot” targets for the pharmaceutical industry will span five days, and attracts 1,000+ attendees (from 21 countries), composed of scientists/technologists, executives, directors, and managers from biopharma, academic, and healthcare organizations. In 2015 the event is comprised of 15 conference tracks, 3 Symposia, 14 short courses, 35+ interactive breakout discussion groups, an exhibit hall of 65 companies, and dedicated poster viewing and networking sessions. The 13th Annual Discovery on Target event assembles an impressive group of 200+ distinguished speakers who look forward to sharing their knowledge, best practices, and expertise with all attendees.DiscoveryOnTarget.com

Conferences by Date with Detail


Digital PCR November 2-4, 2015 • San Diego, CAPolymerase chain reaction (PCR) is an invaluable tool for nucleic acid detection and quantification. As a staple in diagnostics labs, PCR has continued to evolve with scientific need, the latest iteration being digital PCR (dPCR). dPCR increases sensitivity, specificity, and in many cases allows higher throughput. Cambridge Healthtech Institute’s Fourth Annual Digital PCR conference will continue to highlight the importance PCR advances for clinical diagnostics. As always, this event gathers technology providers, early adopters, and platform newcomers to network and discuss digital PCR’s capabilities, limitations, and future applications. This year, key focus will be placed on the technology behind dPCR, interfacing between dPCR and NGS, and emerging technologies and areas of study. Other topics to be addressed include solutions for processing difficult samples and increasing sample throughput, working with extracellular DNA, and guidelines and best practices for digital detection.Healthtech.com/Digital-PCR

Strategic Resource ManagementNovember 2-3, 2015 • Philadelphia, PAAlthough investment in pharma R&D continues to increase, approval of new drugs remains relatively low. This productivity crisis presents new challenges to biopharma R&D in terms of resource management, forecasting, and capacity planning. To counteract the decline in new therapeutics and high risk of product failure, biopharma must adapt with improved performance planning, intelligent outsourcing, and new big data analytics aimed at developing strategic and flexible resource management systems. The 13th Annual “Strategic Resource Management: Enhanced R&D Productivity, Forecasting and Planning”, attracts over 100 senior R&D executives sharing best practices and new ideas on how to enhance R&D productivity, forecasting and planning with important discussions on optimizing resource management, outsourcing, innovation, R&D, clinical capacity planning, forecasting and business intelligence strategies.ExecutiveDecisionMaking.com/ResourceManagement

Portfolio ManagementNovember 3-4, 2015 • Philadelphia, PAIn an environment of declining revenues and uncertain commercial success, biopharma, device and R&D companies need to continuously evaluate their portfolios. Manufacturers must make tough decisions about which products and projects to pursue to optimize long-term revenue and reduce overall risk. The 10th Annual “Portfolio Management: Aligning Portfolio and Productivity with Corporate Strategy to Drive Innovation” attracts over 100 senior R&D executives from the pharma, biotech, device, IT, public and governmental communities who share best practices in project and portfolio management, R&D innovation, decision analysis, forecasting and the improvement of operational models. Effective portfolio

management requires the alignment of portfolio and productivity with corporate strategy, supporting agile development and adaptation of data into planning.ExecutiveDecisionMaking.com/PortfolioManagement

PEGS Europe SummitNovember 2-6, 2015 • Lisbon, PortugalPEGS Europe is the largest European event covering all aspects of protein and antibody engineering. With three consecutive years of 35% growth in attendance, and another year of expanded program coverage, this year’s event will feature 700 attendees, 200 technical presentations, 150 scientific posters, dedicated networking opportunities, exclusive exhibit & poster viewing hours, and interactive roundtable, breakout & panel discussions. PEGSummitEurope.com

FAST: Functional Analysis & Screening TechnologiesNovember 9-11, 2015 • Boston, MAWith the tremendous expense of bringing new drugs to market, a focus on improving the outcome of first-stage research is critical. Recent evidence confirms the need for innovative screening systems utilizing assay design on three-dimensional tissue models and phenotypic models. This functional analysis will allow for more accurate biological response. Cambridge Healthtech Institute is pleased to introduce FAST: Functional Analysis & Screening Technologies Congress to bring together drug research and development teams for practical discussion, solutions and case studies for refining these first-stage drug discovery methods.FastCongress.com



Advances in PreNatal Molecular DiagnosticsNovember 18-19, 2015 • Boston, MA The growing acceptance and availability of NIPT, based on next-gen sequencing of cell-free DNA from maternal blood, is having a dramatic impact on prenatal testing. One result has been the steady decline in the number of women choosing invasive testing, with growing replacement of karyotyping by arrays or in some cases sequencing for analysis of these samples. For non-invasive testing there has been increased differentiation among the leading test service providers. There has been a push to expand NIPT use beyond higher-risk pregnancies, as well as extending the range of genetic conditions reported from the tests, but such changes come at a price. Testing based on isolation of fetal cells from maternal blood would provide an attractive alternative to testing of cell-free DNA, but the commercialization of this approach has faced a range of challenges. Updated comparisons and examination of these issues, and the implementation of these different approaches, will again make for lively discussion and insight into where this field is headed and ways for researchers, test providers, clinicians and clinics to take these developments into consideration.HealthTech.com/Prenatal-Diagnostics

Reproductive Genetic DiagnosticsNovember 18-19, 2015 • Boston, MARapidly evolving technologies are transforming the way reproductive genetic diagnostics and screening are performed, but the differences, limitations, and benefits of these new technologies remain unclear to some. The Inaugural Reproductive Genetic Diagnostics conference aims to examine the latest technologies, including next-generation sequencing (NGS), quantitative PCR, and long fragment read (LFR), and their benefits and applications in carrier screening, preimplantation diagnostics, and product of conception (POC) testing. As these technologies develop and become widespread, we must understand their capabilities, where each technology is best applied, and be sure that they have been analytically and clinically validated. Furthermore, as the technology outpaces practices, we must take a critical eye to the ethical implications of the applications of these technologies, including the regions of the genome that should be sequenced and the types and amount of sequence variation that is necessary for diagnosis. Join this event with your colleagues to meet with clinicians, researchers, developers, and key thought leaders and to examine these topics.HealthTech.com/Reproductive-Genetic-Diagnostics

Re-Entering Antibacterial Drug Development SummitNovember 16-18, 2015 • Boston, MAAccording to the Centers for Disease Control and Prevention, antibiotic-resistant infections are associated with an additional 23,000 deaths and 2 million illnesses in the United States each year. The estimated annual impact of antibiotic-resistant infections on the national economy is $20 billion in excess direct health care costs, and as much as $35 billion in lost productivity from hospitalizations and sick days. By holding the Second Annual Re-Entering Antibacterial Drug Development Summit, we at Cambridge Healthtech Institute are trying to contribute to the efforts to revive antibacterial pipeline, and to improve antimicrobial stewardship in the United States and worldwide. This Summit is designed as a forum for knowledge and opinion exchange between the major stakeholders, who are shaping the current state of antibacterial discovery and development.HealthTech.com/Antibacterial-Drug-Development

Immunogenicity and Bioassay SummitNovember 17-19, 2015 • Baltimore, MDSince 2009, CHI’s Annual Immunogenicity and Bioassay Summit event has gone from strength-to-strength. We always have wonderful input from the regulatory agencies in the form of presentations, breakout discussion leaders and audience participation resulting in intense and lively discussion to help attendees sort out their regulatory challenges. By running Immunogenicity Assessment and Clinical Relevance back-to-back with Optimizing Bioassays for Biologics we provide Directors and Scientists in Bioanalytical Sciences and Assay Development with 30+ presentations spread over 3 days. Immunogenicity Assessment and Clinical Relevance is also back-to-back with Immunogenicity Prediction and Mitigation to provide 3 days and 30+ presentations focusing purely on Immunogenicity. We offer 45 + presentations of case studies and advice form the experts, a choice of 15+ breakout discussions, many posters and an exciting exhibition. This event addresses all the key issues and challenges in Immunogenicity and Bioassays to ensure your product is safe and efficacious in the clinic. We look forward to seeing you at the event.ImmunogenicitySummit.com



PepTalk: The Protein Science WeekJanuary 18-22, 2016 • Boston, MAPepTalk: The Protein Science Week is one of the largest gatherings of protein science researchers in the United States. It offers an array of education, innovation and networking programs, and provides many opportunities to scientists. PepTalk is an annual gathering where industry experts from around the world convene to share case studies, unpublished data, breakthroughs and solutions that support and enhance research, and to gain new perspectives on the evolution of biologics.CHI-Peptalk.com

High-Content Analysis & Phenotypic ScreeningFebruary 11-12, 2016 • San Diego, CACHI’s Thirteenth Annual High-Content Analysis meeting, the premier event showcasing the latest advancements in HCA applications and technologies, returns to San Diego with a new program. Over the years we have observed the technology mature and its adoption spread into many areas of compound screening/evaluation and functional analysis. The High-Content Analysis meeting will focus on the next steps of technology development, including screening of 3D and physiologically relevant complex models, ultra-high resolution and high-throughput imaging, more advanced image analysis and data management, and new assays and applications. The co-located Second Annual Phenotypic Screening meeting will address the advantages of phenotypic screening vs. target-based screening, and focus on assay development, selection of physiologically relevant models and subsequent target identification, as well as case studies of phenotypic screens from leading pharma. Join the original High-Content Analysis event and get access to two tracks featuring a cutting-edge scientific agenda, expanded exhibit hall and technology showcases, and an offering of user group meetings and dinner courses.HighContentAnalysis.com

PANIC: Practical Applications of NMR in IndustryFebruary 15-18, 2016 • Houston, TX

The PANIC meeting is intended to address topics that occur daily in industrial, government, and academic research laboratories whose primary task entails the application of NMR to a diverse set of analytical problems. Topics include quantitation, molecular structure characterization, trace component and mixture analysis, and product support for a variety of materials that include small molecules, polymers, heterogeneous mixtures, natural products, biosimilars, polysaccharides, and proteins. The conference provides in-depth discussions of the “nuts and bolts” of basic NMR experiments that accent the underlying best-practices developed to address these everyday problems. It also explores the regulatory aspects of the applications of these experiments. Greater insights will be provided into the less frequently explored techniques used in NMR such as quantitation, chemometrics, automation, relaxometry, and low-field instrumentation. Attendees will have the opportunity to learn about and discuss applications of NMR to pharmaceuticals, polymers, petroleum, food/agriculture, and plant production that are rarely discussed at other NMR meetings. Ample opportunity will be given to network with people who are experts in inventing NMR experiments to solve real world problems in a timely and efficient manner that is demanded by working in the venue of product delivery. PanicNMR.com

SCOPE: Summit for Clinical Trials Operations ExecutivesFebruary 22-25, 2016 • Miami, FLThe 7th Annual SCOPE Summit, taking place February 23-25, 2016 in Miami, FL, will offer three stimulating days of in-depth discussions in 12 different conferences, 4 pre-conference workshops and 2 symposia focused on issues related to each aspect of clinical trial planning and management: Data Integration, Feasibility, Site Selection and Management, Patient Engagement, Recruitment and Retention, Mobile Tech, Project Management, Outsourcing, Forecasting, Budgeting and Contracting, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Post-Marketing Studies, Observational Research, Statistics and Biomarker-Driven Trials. SCOPESummit.com



Short Course Title Conference / Date / Location

THE BIOPROCESSING SUMMIT

Optimizing Media: Achieving Super Soup August 3, 2015 • Boston, MA

Biophysical Characterization in Assessing the Higher Order Structure (HOS) Fingerprint of Biopharmaceuticals August 3, 2015 • Boston, MA

Accelerated Stability Testing of Biologics August 3, 2015 • Boston, MA

Analytical Strategies for Comparability in Bioprocess Development August 4, 2015 • Boston, MA

Operational Excellence Strategies for Bioprocessing – QbD, DoE and PAT August 4, 2015 • Boston, MA

Protein Aggregation: Mechanism, Characterization and Consequences August 4, 2015 • Boston, MA

Patent Strategies for Bioprocess Scientists August 4, 2015 • Boston, MA

Incorporating the Concepts of Pharmaceutical Quality Systems into Cell Therapy Products August 4, 2015 • Boston, MA

Transient Protein Production in Mammalian Cells August 6, 2015 • Boston, MA

ABC: Anything But Chromatography – Precipitation, Crystallization and Flocculation August 6, 2015 • Boston, MA

NEXT GENERATION DX SUMMIT

Use of FFPE/Fixed Tissues for Clinical Research August 17, 2015 • Washington, DC

Method Validation According to CLSI Guidelines August 17, 2015 • Washington, DC

Practical Considerations for NGS Data Analysis and Interpretation August 17, 2015 • Washington, DC

Biomarkers for Cancer Immunotherapy August 17, 2015 • Washington, DC

Microfluidics for Point-of-Care August 17, 2015 • Washington, DC

Establishing the Value of Diagnostic Tests August 17, 2015 • Washington, DC

NGS as a Diagnostics Platform August 17, 2015 • Washington, DC

Detection and Characterization of Circulating Biomarkers August 17, 2015 • Washington, DC

Regulatory Compliance in Molecular Diagnostics August 17, 2015 • Washington, DC

Use of CLIA-Waived POC and Rapid Diagnostic Tests in Community Pharmacies August 19, 2015 • Washington, DC

NGS for Infectious Disease Diagnostics August 19, 2015 • Washington, DC

Regulatory and Reimbursement Considerations with NGS and Other Multiplex Assays August 19, 2015 • Washington, DC

IMVACS: IMMUNOTHERAPY AND VACCINE SUMMIT

Targeting the Cancer Mutanome August 25, 2015 • Boston, MA

Adoptive Therapy with Car T Cells August 27, 2015 • Boston, MADISCOVERY ON TARGET

Cancer Metabolism: Pathways, Targets and Clinical Updates September 21, 2015 • Boston, MA

Leveraging Data and Analytics for Drug Discovery September 21, 2015 • Boston, MA

Setting up Effective RNAi Screens: From Design to Data to Validation September 21, 2015 • Boston, MA

Phenotypic Screening and Chemical Probe Development September 21, 2015 • Boston, MA

GPCR Structure-Based Drug Discovery September 21, 2015 • Boston, MA

Targeting of GPCRs with Monoclonal Antibodies September 21, 2015 • Boston, MA

Setting Up Effective Functional Screens Using 3D Cell Cultures September 21, 2015 • Boston, MA

Targeting Protein-Protein Interactions: Biophysical Approaches September 21, 2015 • Boston, MA

Preclinical Animal Models for Ocular Indications September 21, 2015 • Boston, MA

Introduction to Allosteric Modulators and Biased Ligands of GPCRs September 23, 2015 • Boston, MA

Introduction to Targeted Covalent Inhibitors September 23, 2015 • Boston, MA

Assays and High-Throughput Screening for Novel Epigenetic Inhibitors September 23, 2015 • Boston, MA

Gamification and Drug Target Challenges September 23, 2015 • Boston, MA

A Primer to Gene Editing: Tools and Applications September 23, 2015 • Boston, MAUsing Mechanistic Physiological Models in Drug Development: A Proven Quantitative Systems Pharmacology (QSP) Approach

September 23, 2015 • Boston, MA

DIGITAL PCRDigital PCR: A Technology Primer November 2, 2015 • San Diego, CA

Short Course Schedule HOLD A COURSE AT YOUR FACILITY.For more information, please contact Edel O’Regan at 781-972-5423 or email: [email protected]


Short Course Title Conference / Date / Location

Single-Cell Genomic Analysis November 3, 2015 • San Diego, CAPEGS EUROPE

Engineering of Bispecific Antibodies November 2, 2015 • Lisbon, Portugal

CHO Cell Engineering November 2, 2015 • Lisbon, Portugal

Protein Purification Strategies: Dealing with Proteins that are Prone to Aggregate November 2, 2015 • Lisbon, Portugal

Mutation and Selection Strategies for Multi-Parameter Antibody Optimization November 2, 2015 • Lisbon, Portugal

In Silico Antibody Design with BioLuminate November 2, 2015 • Lisbon, Portugal

Troubleshooting and Engineering of Antibody Constructs November 5, 2015 • Lisbon, Portugal

The Challenge of Protein Aggregation and Formation of Sub Visible Particles in the Development of Biopharmaceuticals

November 5, 2015 • Lisbon, Portugal

Advanced Techniques for Characterization of Protein Aggregates, Particulates and Contaminants November 5, 2015 • Lisbon, Portugal

Immunotherapy in the 21st Century: More Specificity, More Potency, Better Targeting November 5, 2015 • Lisbon, PortugalSTRATEGIC RESOURCE MANAGEMENT

Project Portfolio Management Certification Master Class November 5-6, 2015 • Philadelphia, PA

FAST CONGRESS: FUNCTIONAL ANALYSIS & SCREENING TECHNOLOGIES

Introduction to High-Content Phenotypic Screening TBA • Boston, MA

Exploring 3D Printing, Bioinks and Scaffolds TBA • Boston, MAStem Cell Models for Drug Discovery TBA • Boston, MAEngineering Microfluidic Cell Culture Chips TBA • Boston, MAHow to Meet the Need for Physiologically-Relevant Assays TBA • Boston, MA

IMMUNOGENICITY & BIOASSAY SUMMIT

Basics of Immunogenicity Testing November 16, 2015 • Baltimore, MD

Challenges of Immunogenicity Assessment November 16, 2015 • Baltimore, MD

Immunogenicity Risk Assessment and Regulatory Strategy November 18, 2015 • Baltimore, MD

Strategic Bioassay Design and Analysis November 18, 2015 • Baltimore, MDPEPTALK: THE PROTEIN SCIENCE WEEK

Production Challenges for Complex Biologics: ADCs, Bispecifics and Fusion Proteins January 18, 2016 • San Diego, CA

A Rational Approach to Formulation Development of Biologic Therapeutics January 18, 2016 • San Diego, CA

Genome Editing Using CRISPR January 18, 2016 • San Diego, CAAccelerated Stability Testing of Biologics January 18, 2016 • San Diego, CA

Establishing the Business Case for Single-Use and Continuous Processing January 18, 2016 • San Diego, CA

Targeting of GPCRs with Monoclonal Antibodies January 20, 2016 • San Diego, CAAffecting Effector Function: Engineering the Fc Region January 20, 2016 • San Diego, CA

Protein Aggregation: Mechanism, Characterization and Consequences January 20, 2016 • San Diego, CA

Transient Protein Production in Mammalian Cells January 20, 2016 • San Diego, CA

Materials in Contact with Biologics: Understanding Risk to Quality and Safety January 20, 2016 • San Diego, CA

Protein Purification Strategies: Dealing with Proteins that Are Prone to Aggregate January 20, 2016 • San Diego, CA

HIGH-CONTENT ANALYSIS & PHENOTYPIC SCREENING

Short Course 1 (Title TBA) February 10, 2016 • San Diego, CA

Short Course 2 (Title TBA) February 11, 2016 • San Diego, CA

SCOPE: SUMMIT FOR CLINICAL TRIAL EXECUTIVES

How to Accelerate Site Selection, Study Activation, and Patient Recruitment for Fast Clinical Trials TBA • Miami, FL

Short Course 2 (Title TBA) TBA • Miami, FL



Short Course Schedule

August 2015 – February 2016 Catalog | 16 healthtech.com

Cambridge Healthtech Institute250 First Avenue, Suite 300 | Needham, MA 02494

T: (781) 972-5400 or Toll-free in the U.S. 888-999-6288 | F: (781) 972-5425

Your Life Science NetworkCambridge Healthtech Institute

cambridge healthtech institute · key events 2015 2016 march 6-11, 2016 miscone north convention...

Documents